ＪＣＲファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2010/03/16 | 1,377 | 1,410 | 1,370 | 1,377 | -30 | -2.1% | 239,000 |
| 2010/03/15 | 1,430 | 1,450 | 1,398 | 1,407 | -32 | -2.2% | 246,000 |
| 2010/03/12 | 1,410 | 1,450 | 1,381 | 1,439 | +39 | +2.8% | 289,000 |
| 2010/03/11 | 1,480 | 1,503 | 1,385 | 1,400 | -84 | -5.7% | 655,000 |
| 2010/03/10 | 1,412 | 1,484 | 1,363 | 1,484 | +55 | +3.8% | 609,000 |
| 2010/03/09 | 1,456 | 1,480 | 1,421 | 1,429 | -54 | -3.6% | 378,000 |
| 2010/03/08 | 1,510 | 1,524 | 1,472 | 1,483 | -27 | -1.8% | 255,000 |
| 2010/03/05 | 1,505 | 1,535 | 1,497 | 1,510 | ±0 | ±0% | 253,000 |
| 2010/03/04 | 1,545 | 1,545 | 1,500 | 1,510 | +2 | +0.1% | 377,000 |
| 2010/03/03 | 1,459 | 1,513 | 1,459 | 1,508 | +77 | +5.4% | 577,000 |
| 2010/03/02 | 1,348 | 1,449 | 1,342 | 1,431 | +24 | +1.7% | 378,000 |
| 2010/03/01 | 1,409 | 1,459 | 1,401 | 1,407 | +16 | +1.2% | 546,000 |
| 2010/02/26 | 1,337 | 1,398 | 1,320 | 1,391 | +73 | +5.5% | 417,000 |
| 2010/02/25 | 1,302 | 1,325 | 1,296 | 1,318 | +21 | +1.6% | 372,000 |
| 2010/02/24 | 1,270 | 1,297 | 1,256 | 1,297 | +24 | +1.9% | 210,000 |
| 2010/02/23 | 1,270 | 1,277 | 1,251 | 1,273 | +5 | +0.4% | 194,000 |
| 2010/02/22 | 1,184 | 1,273 | 1,172 | 1,268 | +80 | +6.7% | 396,000 |
| 2010/02/19 | 1,219 | 1,219 | 1,170 | 1,188 | -31 | -2.5% | 147,000 |
| 2010/02/18 | 1,228 | 1,228 | 1,211 | 1,219 | -1 | -0.1% | 118,000 |
| 2010/02/17 | 1,210 | 1,229 | 1,205 | 1,220 | +17 | +1.4% | 181,000 |
| 2010/02/16 | 1,245 | 1,260 | 1,201 | 1,203 | -27 | -2.2% | 370,000 |
| 2010/02/15 | 1,180 | 1,230 | 1,162 | 1,230 | +44 | +3.7% | 220,000 |
| 2010/02/12 | 1,144 | 1,191 | 1,130 | 1,186 | +61 | +5.4% | 224,000 |
| 2010/02/10 | 1,144 | 1,144 | 1,106 | 1,125 | -10 | -0.9% | 142,000 |
| 2010/02/09 | 1,141 | 1,151 | 1,102 | 1,135 | -23 | -2% | 177,000 |
| 2010/02/08 | 1,167 | 1,186 | 1,158 | 1,158 | -16 | -1.4% | 144,000 |
| 2010/02/05 | 1,158 | 1,176 | 1,138 | 1,174 | -14 | -1.2% | 236,000 |
| 2010/02/04 | 1,193 | 1,208 | 1,163 | 1,188 | +3 | +0.3% | 250,000 |
| 2010/02/03 | 1,179 | 1,218 | 1,158 | 1,185 | +1 | +0.1% | 453,000 |
| 2010/02/02 | 1,126 | 1,194 | 1,100 | 1,184 | +99 | +9.1% | 748,000 |
| 2010/02/01 | 1,070 | 1,099 | 1,064 | 1,085 | +35 | +3.3% | 261,000 |
| 2010/01/29 | 1,047 | 1,080 | 1,030 | 1,050 | ±0 | ±0% | 82,000 |
| 2010/01/28 | 1,030 | 1,109 | 1,030 | 1,050 | +19 | +1.8% | 213,000 |
| 2010/01/27 | 1,021 | 1,042 | 1,015 | 1,031 | +10 | +1% | 136,000 |
| 2010/01/26 | 1,060 | 1,079 | 1,021 | 1,021 | -60 | -5.6% | 232,000 |
| 2010/01/25 | 1,130 | 1,134 | 1,045 | 1,081 | -36 | -3.2% | 309,000 |
| 2010/01/22 | 975 | 1,117 | 970 | 1,117 | +150 | +15.5% | 522,000 |
| 2010/01/21 | 1,009 | 1,009 | 955 | 967 | +32 | +3.4% | 168,000 |
| 2010/01/20 | 935 | 939 | 922 | 935 | +6 | +0.6% | 23,000 |
| 2010/01/19 | 944 | 945 | 924 | 929 | -15 | -1.6% | 32,000 |
| 2010/01/18 | 942 | 945 | 936 | 944 | +4 | +0.4% | 27,000 |
| 2010/01/15 | 942 | 958 | 935 | 940 | -10 | -1.1% | 57,000 |
| 2010/01/14 | 941 | 954 | 938 | 950 | +7 | +0.7% | 32,000 |
| 2010/01/13 | 941 | 955 | 933 | 943 | +6 | +0.6% | 88,000 |
| 2010/01/12 | 950 | 951 | 935 | 937 | -14 | -1.5% | 40,000 |
| 2010/01/08 | 935 | 957 | 932 | 951 | +12 | +1.3% | 63,000 |
| 2010/01/07 | 961 | 967 | 933 | 939 | -31 | -3.2% | 102,000 |
| 2010/01/06 | 998 | 998 | 969 | 970 | -15 | -1.5% | 80,000 |
| 2010/01/05 | 1,002 | 1,010 | 968 | 985 | -45 | -4.4% | 157,000 |
| 2010/01/04 | 1,049 | 1,059 | 1,020 | 1,030 | +2 | +0.2% | 114,000 |
3601～
3650
件表示中 / 6844件
類似銘柄と比較する
現在ご覧いただいている「ＪＣＲファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＪＣＲファーマ | 75,700円 | -3.7% | -36.7% | 2.64% | 24.93倍 | 1.63倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| ゼリア新薬 | 229,200円 | +13.6% | +29.2% | 2.01% | 11.89倍 | 1.14倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 114,000円 | +197.7% | - | 0.00% | 46.59倍 | 1.49倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 148,500円 | +3.2% | +4.5% | 3.50% | 17.06倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 215,900円 | +0.4% | -8.4% | 2.45% | 28.54倍 | 1.62倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
